Sutro Biopharma, Inc.
STRO
$0.7139
-$0.0201-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.51% | -15.63% | 9.32% | 8.77% | 13.28% |
| Total Receivables | -56.67% | -76.12% | -59.97% | -30.49% | 217.03% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 147.17% | 80.77% | 14.71% | 1.83% | -43.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -18.94% | -18.56% | 6.43% | 7.64% | 16.61% |
|
|
|||||
| Total Current Assets | -18.94% | -18.56% | 6.43% | 7.64% | 16.61% |
| Net Property, Plant & Equipment | -21.66% | -19.86% | -17.95% | -18.51% | -15.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -85.70% | 80.90% | 93.94% | 40.60% | 60.02% |
| Total Assets | -20.32% | -17.74% | 4.66% | 5.19% | 12.68% |
|
|
|||||
| Total Accounts Payable | 8.91% | 10.96% | 12.51% | 57.83% | 48.50% |
| Total Accrued Expenses | 29.34% | 17.69% | 50.78% | 80.97% | 58.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.36% | -28.63% | -45.89% | -57.02% | -63.92% |
| Total Finance Division Other Current Liabilities | 112.79% | 85.79% | 181.36% | 205.81% | 101.65% |
| Total Other Current Liabilities | 112.79% | 85.79% | 181.36% | 205.81% | 101.65% |
| Total Current Liabilities | 67.33% | 40.69% | 78.37% | 93.65% | 33.66% |
|
|
|||||
| Total Current Liabilities | 67.33% | 40.69% | 78.37% | 93.65% | 33.66% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -36.29% | -32.31% | -28.97% | -26.14% | -23.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.91% | -4.48% | -13.24% | -13.51% | 140.43% |
| Total Liabilities | 13.71% | 6.70% | 6.65% | 8.60% | 76.93% |
|
|
|||||
| Common Stock & APIC | 16.94% | 17.26% | 17.46% | 17.54% | 4.01% |
| Retained Earnings | -39.70% | -40.66% | -20.99% | -23.00% | -22.87% |
| Treasury Stock & Other | 92.04% | 85.71% | 1,414.29% | -1,118.75% | -5.61% |
| Total Common Equity | -126.33% | -70.20% | -1.00% | -1.64% | -47.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -126.33% | -70.20% | -1.00% | -1.64% | -47.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -126.33% | -70.20% | -1.00% | -1.64% | -47.13% |
|
|
|||||